You're viewing our new website - find out more

Publication - Consultation paper

The Modern Outpatient: A Collaborative Approach 2017-2020

Published: 2 Dec 2016
Health Performance and Delivery Directorate
Part of:
Health and social care

Transforming the patient experience by optimising the roles of all clinicians, utilising new technologies and putting the patient at the centre of care.

44 page PDF

359.3 kB

44 page PDF

359.3 kB

The Modern Outpatient: A Collaborative Approach 2017-2020
2. Key Facts

44 page PDF

359.3 kB

2. Key Facts

2.1 NHSScotland delivers almost 5 million outpatient appointments every year. Patients attend outpatient appointments for one of three broad reasons:

  • an initial referral to acute care to get more specialist opinion and diagnosis;
  • for treatment, which may be a series of treatments over time; or
  • for follow-up to check on outcomes and/or continuing symptoms.

During 2015-16 there were a total of 4,500,280 outpatient attendances, of which 1,486,522 were new and 3,013,728 were return appointments.

Return appointments accounted for 67% of all acute outpatient activity (see Annex 1).

During the period 2007/08 to 2015/16:

2.2 There has been an 8% increase in new outpatient attendances to all specialties (excluding A&E), (see Annex 2).

Some high volume specialties have experienced significant growth in new attendances:

Gastroenterology 104%
Respiratory medicine 78%
Dermatology 22%
General surgery 26%

2.3 Some high volume specialties have experienced significant growth in all attendances (new and return):

Gastroenterology 63%
Respiratory medicine 44%
Dermatology 15%
ENT 11%

Redesign in action: Redesign which delivers results

Sustained service redesign which addresses the management of both new and return patients has reversed the growth trends in appointments. Fracture Pathway Redesign and the development of Musculoskeletal ( MSK) services are having a positive impact in off-setting potential growth. Trauma and Orthopaedics new and return appointments have reduced by 13% since 2007/9 through clinically-led redesign of pathways.